Association of the disease duration and administered therapy with metabolic syndrome in patients with systemic lupus erythematosus
Aim. The aim of the paper was to examine the impact of disease duration and administered therapy on the development of metabolic syndrome (MetS) in patients with systemic lupus erythematosus (SLE). Material and methods. This study involved 55 patients (50 females and 5 males) with the diagnosis and 49 healthy controls of similar age. MetS was defin...
By Jovana Cvetković, Sonja Stojanović, Ivan Tasić, Bojana Stamenković, Jovan Nedović, Sanja Stojanović
The impact of disease activity in patients with rheumatoid arthritis on metabolic syndrome and cardiovascular risk assessment
...
By Ivana Aleksić, Sonja Stojanović, Ivan Tasić, Bojana Stamenković